These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16821776)

  • 1. 2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 3. Synthesis, pharmacokinetics, and in vivo potency.
    Borthwick AD; Davies DE; Exall AM; Hatley RJ; Hughes JA; Irving WR; Livermore DG; Sollis SL; Nerozzi F; Valko KL; Allen MJ; Perren M; Shabbir SS; Woollard PM; Price MA
    J Med Chem; 2006 Jul; 49(14):4159-70. PubMed ID: 16821776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 2. Synthesis, chirality, and pharmacokinetics.
    Borthwick AD; Davies DE; Exall AM; Livermore DG; Sollis SL; Nerozzi F; Allen MJ; Perren M; Shabbir SS; Woollard PM; Wyatt PG
    J Med Chem; 2005 Nov; 48(22):6956-69. PubMed ID: 16250654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyridyl-2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists: synthesis, pharmacokinetics, and in vivo potency.
    Borthwick AD; Liddle J; Davies DE; Exall AM; Hamlett C; Hickey DM; Mason AM; Smith IE; Nerozzi F; Peace S; Pollard D; Sollis SL; Allen MJ; Woollard PM; Pullen MA; Westfall TD; Stanislaus DJ
    J Med Chem; 2012 Jan; 55(2):783-96. PubMed ID: 22239250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The design of orally bioavailable 2, 5-diketopiperazine oxytocin antagonists: from concept to clinical candidate for premature labor.
    Borthwick AD; Liddle J
    Med Res Rev; 2011 Jul; 31(4):576-604. PubMed ID: 20027670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and development of a new class of potent, selective, orally active oxytocin receptor antagonists.
    Quattropani A; Dorbais J; Covini D; Pittet PA; Colovray V; Thomas RJ; Coxhead R; Halazy S; Scheer A; Missotten M; Ayala G; Bradshaw C; De Raemy-Schenk AM; Nichols A; Cirillo R; Tos EG; Giachetti C; Golzio L; Marinelli P; Church DJ; Barberis C; Chollet A; Schwarz MK
    J Med Chem; 2005 Dec; 48(24):7882-905. PubMed ID: 16302826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of (2S,4Z)-N-[(2S)-2-hydroxy-2-phenylethyl]-4-(methoxyimino) -1-[(2'-methyl[1,1'-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a new potent and selective nonpeptide antagonist of the oxytocin receptor.
    Cirillo R; Gillio Tos E; Schwarz MK; Quattropani A; Scheer A; Missotten M; Dorbais J; Nichols A; Borrelli F; Giachetti C; Golzio L; Marinelli P; Thomas RJ; Chevillard C; Laurent F; Portet K; Barberis C; Chollet A
    J Pharmacol Exp Ther; 2003 Jul; 306(1):253-61. PubMed ID: 12660315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines.
    Bell IM; Erb JM; Freidinger RM; Gallicchio SN; Guare JP; Guidotti MT; Halpin RA; Hobbs DW; Homnick CF; Kuo MS; Lis EV; Mathre DJ; Michelson SR; Pawluczyk JM; Pettibone DJ; Reiss DR; Vickers S; Williams PD; Woyden CJ
    J Med Chem; 1998 Jun; 41(12):2146-63. PubMed ID: 9622556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,5-Diketopiperazines as potent and selective oxytocin antagonists 1: Identification, stereochemistry and initial SAR.
    Wyatt PG; Allen MJ; Borthwick AD; Davies DE; Exall AM; Hatley RJ; Irving WR; Livermore DG; Miller ND; Nerozzi F; Sollis SL; Szardenings AK
    Bioorg Med Chem Lett; 2005 May; 15(10):2579-82. PubMed ID: 15863320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction of a cis-prolyl mimic in position 7 of the peptide hormone oxytocin does not result in antagonistic activity.
    Wittelsberger A; Patiny L; Slaninova J; Barberis C; Mutter M
    J Med Chem; 2005 Oct; 48(21):6553-62. PubMed ID: 16220972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The discovery of GSK221149A: a potent and selective oxytocin antagonist.
    Liddle J; Allen MJ; Borthwick AD; Brooks DP; Davies DE; Edwards RM; Exall AM; Hamlett C; Irving WR; Mason AM; McCafferty GP; Nerozzi F; Peace S; Philp J; Pollard D; Pullen MA; Shabbir SS; Sollis SL; Westfall TD; Woollard PM; Wu C; Hickey DM
    Bioorg Med Chem Lett; 2008 Jan; 18(1):90-4. PubMed ID: 18032036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent and orally bioavailable 8-bicyclo[2.2.2]octylxanthines as adenosine A1 receptor antagonists.
    Kiesman WF; Zhao J; Conlon PR; Dowling JE; Petter RC; Lutterodt F; Jin X; Smits G; Fure M; Jayaraj A; Kim J; Sullivan G; Linden J
    J Med Chem; 2006 Nov; 49(24):7119-31. PubMed ID: 17125264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperazinyl glutamate pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.
    Parlow JJ; Burney MW; Case BL; Girard TJ; Hall KA; Harris PK; Hiebsch RR; Huff RM; Lachance RM; Mischke DA; Rapp SR; Woerndle RS; Ennis MD
    J Med Chem; 2010 Mar; 53(5):2010-37. PubMed ID: 20141147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the rat.
    McCafferty GP; Pullen MA; Wu C; Edwards RM; Allen MJ; Woollard PM; Borthwick AD; Liddle J; Hickey DM; Brooks DP; Westfall TD
    Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R299-305. PubMed ID: 17395790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel, orally bioavailable gamma-aminoamide CC chemokine receptor 2 (CCR2) antagonists.
    Pasternak A; Marino D; Vicario PP; Ayala JM; Cascierri MA; Parsons W; Mills SG; Maccoss M; Yang L
    J Med Chem; 2006 Aug; 49(16):4801-4. PubMed ID: 16884289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtlety of the structure-affinity and structure-efficacy relationships around a nonpeptide oxytocin receptor agonist.
    Frantz MC; Rodrigo J; Boudier L; Durroux T; Mouillac B; Hibert M
    J Med Chem; 2010 Feb; 53(4):1546-62. PubMed ID: 20104850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm labor.
    Williams PD; Anderson PS; Ball RG; Bock MG; Carroll L; Chiu SH; Clineschmidt BV; Culberson JC; Erb JM; Evans BE
    J Med Chem; 1994 Mar; 37(5):565-71. PubMed ID: 8126695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands.
    Albizu L; Teppaz G; Seyer R; Bazin H; Ansanay H; Manning M; Mouillac B; Durroux T
    J Med Chem; 2007 Oct; 50(20):4976-85. PubMed ID: 17850055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G
    Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT6 receptor antagonists.
    Ahmed M; Briggs MA; Bromidge SM; Buck T; Campbell L; Deeks NJ; Garner A; Gordon L; Hamprecht DW; Holland V; Johnson CN; Medhurst AD; Mitchell DJ; Moss SF; Powles J; Seal JT; Stean TO; Stemp G; Thompson M; Trail B; Upton N; Winborn K; Witty DR
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4867-71. PubMed ID: 16143522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent and orally active non-peptide antagonists of the human melanocortin-4 receptor based on a series of trans-2-disubstituted cyclohexylpiperazines.
    Tucci FC; White NS; Markison S; Joppa M; Tran JA; Fleck BA; Madan A; Dyck BP; Parker J; Pontillo J; Arellano LM; Marinkovic D; Jiang W; Chen CW; Gogas KR; Goodfellow VS; Saunders J; Foster AC; Chen C
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4389-95. PubMed ID: 16098742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.